Nuwellis, Inc. (NUWE)

Market Cap	3.67M
Revenue (ttm)	8.97M
Net Income (ttm)	-17.08M
Shares Out	3.67M
EPS (ttm)	-33.46
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	168,745
Open	1.010
Previous Close	1.010
Day's Range	1.000 - 1.060
52-Week Range	0.920 - 30.100
Beta	0.30
Analysts	Strong Buy
Price Target	17.00 (+1,600.0%)
Earnings Date	Nov 11, 2024

About NUWE

Nuwellis, Inc., a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company offers Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure. Its Aquadex FlexFlow system includes a console, disposable blood circuit set, and disposable catheter. The company sells its products to hospitals and clinics through its direct salesforce in the United States; and through independent specialty distributors in Aus...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1999
• Employees: 59
• Stock Exchange: NASDAQ
• Ticker Symbol: NUWE
• Website: https://www.nuwellis.com

Financial Performance

In 2023, Nuwellis's revenue was $8.86 million, an increase of 3.76% compared to the previous year's $8.54 million. Losses were -$22.63 million, 55.8% more than in 2022.

Analyst Forecast

According to one analyst, the rating for NUWE stock is "Strong Buy" and the 12-month stock price forecast is $17.0.

Price Target

$17.0

(1,600.00% upside)

Analyst Consensus: Strong Buy